Cover art for Hana Securities Targets Celltrion at 310,000 Won

Hana Securities Targets Celltrion at 310,000 Won

Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth.

By ·

Nov 18, 2026

7 cards · 1m 10s · tap to begin

From · · · 1m 10s

Hana Securities Targets Celltrion at 310,000 Won

Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth.

In brief

Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth. Hana Securities initiates Celltrion coverage with a 310,000 won target, citing U.S. biosimilar sales as growth driver. Originally reported by BigGo Finance.

Hana Securities Initiates Coverage

Hana Securities Initiates Celltrion Coverage With 310,000 Won Target, Betting on U.S. Direct Biosimilar Sales as Growth Engine

Hana Securities has initiated coverage on South Korea's Celltrion with a 'Buy' rating and a target price of 310,000 won.

Q3 Revenue and Profit Growth

Third-quarter revenue rose 53.1% year-over-year to 1.5755 trillion won, with operating profit up 74.3% to 525.3 billion won.

U.S. Direct Sales Catalyst

Direct sales in the U.S. are driving growth, with five newly launched products improving profitability.

Full-Year Projections

Hana Securities Initiates Celltrion Coverage With 310,000 Won Target, Betting on U.S. Direct Biosimilar Sales as Growth Engine

Full-year revenue projected at 5.8478 trillion won, exceeding company guidance by 40.5%.

U.S. Healthcare Policy Impact

Democrats securing Senate and House control in midterm elections may boost biosimilar demand through Medicaid expansion.

Eli Lilly Contract Manufacturing

Celltrion earns contract manufacturing revenue from Eli Lilly after acquiring the Branchburg plant in the U.S.

Stock Outlook

Celltrion stock could surpass previous high if U.S. biosimilar sales continue to grow.

The big picture

Hana Securities initiates Celltrion coverage with a 310,000 won target, citing U.S. biosimilar sales as growth driver.

Read the original on BigGo Finance

Read the TL;DR — this story on one card.

More news from the United States

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on hana securities and related topics.